3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase NA
2
Phase 3
2
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
133
Recurrence
33
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Neoplasms, Plasma Cell
15
Neoplasms
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia
7
Immunoglobulin Light-chain Amyloidosis
7
Lymphoma, Non-Hodgkin
6
Amyloidosis
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma
5
Hematologic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Burkitt Lymphoma
5
Paraproteinemias
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Acute
4
Hematologic Diseases
4
Blood Protein Disorders
4
Neoplasm Metastasis
3
Myelodysplastic Syndromes
3
Lymphoma, B-Cell
3
Lung Neoplasms
3
Esophageal Neoplasms
3
Corneal Diseases
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Interventions
Temozolomide
26
Bevacizumab
14
Radiosurgery
12
Radiotherapy
9
pembrolizumab
8
Carboplatin
8
Trastuzumab
6
temsirolimus
5
Sirolimus
5
Erlotinib Hydrochloride
5
abemaciclib
4
Paclitaxel
4
Irinotecan
4
Capecitabine
4
tipifarnib
3
Sorafenib
3
Radiation
3
Mental Status and Dementia Tests
3
Ipilimumab
3
Everolimus
3
Aminolevulinic Acid
3
130-nm albumin-bound paclitaxel
3
tucatinib
2
pertuzumab
2
fludarabine
2
durvalumab
2
alovudine
2
alectinib
2
Vorinostat
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Brain Neoplasms
×
Dexamethasone
×
Clear all
NCT05789589
2026-03-04
ADORATION
Baptist Health South Florida
Phase 1/2
Recruiting
46 enrolled